Abiopharma

The Confidence Behind VinFasts 10-Year Promise

Natera to Showcase Organ Health Leadership with 21 Presentations at the American Transplant Congress

Alibaba Group Announces Filing of Annual Report on Form 20-F for Fiscal Year 2026

NIQ and Ogury Collaborate to Enhance Media Planning and Audience Strategy with GeoPurchase Insights

Citi and CREATE-Research Report: Innovation in Asset Management Pivots to ‘Operational Alpha’

Organon et Samsung Bioepis élargissent leur entente pour la commercialisation de PYZCHIVA® (ustékinumab), un biosimilaire de référence à STELARA® (ustékinumab) au Canada

Share Buy Back - Daily Share Buy-Back Notice: Daily Share Buy-Back Notice

Share Buy Back - Daily Share Buy-Back Notice: Daily Share Buy-Back Notice

Forrester abre el plazo de presentación de candidaturas para sus 2026 B2B Awards en EMEA

Opening of Trading on June 19 2026-FATTAL HOLD B6